Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.
A medical technology trade association has warned that the US tariffs recently implemented in response to Chinese IP theft may hinder patient access to life-saving technologies.
The US is leading the way in synthetic biology patent filings, according to a report released earlier this month from patent search software company PatSnap.
Humanitarian organisation Médecins Sans Frontières has challenged a patent owned by Gilead in China.
US-based biopharmaceutical company Sage Therapeutics and Japan-based pharmaceutical corporation Shionogi have entered into a strategic collaboration to develop an antidepressant drug.
India’s Drug Technical Advisory Board, which advises the government, has reportedly approved a “track and trace” proposal that will allow Indian consumers to identify whether their medicine is genuine simply by sending a text message.
Biopharmaceutical company Celgene has ditched its trademark quarrel with the owners of India-based online pharmacies importing generics into the US.
India’s Supreme Court has refused to stay an order which held that agricultural company Monsanto’s patent on genetically modified cotton seeds is invalid.
Japan-based Chugai Pharmaceuticals has announced it has withdrawn its patent infringement claim against generic anti-cancer business Nippon Kayaku.
Agriculture company Monsanto suffered a loss in India yesterday when the High Court of Delhi concluded that the company’s patent on genetically modified cotton seeds is not valid.